Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Basik

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Molecular Endocrinology (Baltimore, Md.)|September 2, 2016
Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast CancerStéphanie Légaré, Mark Basik
Breast Cancer Research : BCR|September 8, 2017
SPEN, a new player in primary cilia formation and cell migration in breast cancerStéphanie Légaré, Catherine Chabot, Mark Basik
BMC Medical Genomics|January 29, 2011
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Cristiano Ferrario, Mark Basik
Biotechniques|September 30, 2003
Integration of genomic technologies for accelerated cancer drug developmentMark Basik, Spyro Mousses, Jeffrey Trent
Studies in History and Philosophy of Science|February 20, 2024
Histology agnosticism: Infra-molecularizing disease?Jonah Campbell, Alberto Cambrosio, Mark Basik
Oncology Letters|May 13, 2024
Personalized circulating tumor DNA response to local radiotherapy in a patient with an early lobular breast cancer: A case reportMariana Pilon Capella, Parvaneh Fallah, Mark Basik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 10, 2026
Mechanisms of resistance to antibody-drug conjugates in breast cancerBaris Cerci, Ozge Saatci, Mark Basik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancerSaima Hassan, Andrea Baccarelli, Ombretta Salvucci, et al.
Current Opinion in Biotechnology|December 7, 2007
Tissue microarrays: emerging standard for biomarker validationSaima Hassan, Cristiano Ferrario, Aline Mamo, et al.
Omics : a Journal of Integrative Biology|October 31, 2006
Microarrays as validation strategies in clinical samples: tissue and protein microarraysAdriana Aguilar-Mahecha, Saima Hassan, Cristiano Ferrario, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Molecular Endocrinology (Baltimore, Md.)|September 2, 2016
Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast CancerStéphanie Légaré, Mark Basik
Breast Cancer Research : BCR|September 8, 2017
SPEN, a new player in primary cilia formation and cell migration in breast cancerStéphanie Légaré, Catherine Chabot, Mark Basik
BMC Medical Genomics|January 29, 2011
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Cristiano Ferrario, Mark Basik
Biotechniques|September 30, 2003
Integration of genomic technologies for accelerated cancer drug developmentMark Basik, Spyro Mousses, Jeffrey Trent
Studies in History and Philosophy of Science|February 20, 2024
Histology agnosticism: Infra-molecularizing disease?Jonah Campbell, Alberto Cambrosio, Mark Basik
Oncology Letters|May 13, 2024
Personalized circulating tumor DNA response to local radiotherapy in a patient with an early lobular breast cancer: A case reportMariana Pilon Capella, Parvaneh Fallah, Mark Basik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 10, 2026
Mechanisms of resistance to antibody-drug conjugates in breast cancerBaris Cerci, Ozge Saatci, Mark Basik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancerSaima Hassan, Andrea Baccarelli, Ombretta Salvucci, et al.
Current Opinion in Biotechnology|December 7, 2007
Tissue microarrays: emerging standard for biomarker validationSaima Hassan, Cristiano Ferrario, Aline Mamo, et al.
Omics : a Journal of Integrative Biology|October 31, 2006
Microarrays as validation strategies in clinical samples: tissue and protein microarraysAdriana Aguilar-Mahecha, Saima Hassan, Cristiano Ferrario, et al.
Pageof 13